In turn, the enrolment period is often extended to allow recruitment targets to be achieved, which consequently increases trial costs as well. The uncertain regulatory environment is a key contributor ...

There is a significant discourse in the literature when estimating clinical trial costs due to the lack of transparency throughout the industry regarding the true expense of bringing a drug from ...